New Delhi, 31 May 2024: The Drugs Controller General of India (DCGI), Rajeev Raghuvanshi, has mandated that medical device manufacturers and in-vitro diagnostic (IVD) testing laboratories comply with the Bureau of Indian Standards (BIS) for product testing.

This direct......
View Details

Related News

• The coming booster for Indian pharma stocks: US Biosecure Act (10-09-2024)

---

• Telangana DCA officials seized 635 bottles of Glycoril cough syrup, along with printed labels (10-09-2024)

---

• GST reduced on Cancer life-saving drugs from 12% to 5% (10-09-2024)

---

• Penicillin G & Clavulanic acid Plant to start production soon: DoP (10-09-2024)

---

• Use latest tech to develop Green Pharma City: CM Revanth Reddy to officials (10-09-2024)

---

• FSSAI issues draft to include natamycin as preservative in additives norms (10-09-2024)

---

• Domestic formulations biz expected to grow 9-10% over next decade: Glenmark (09-09-2024)

---

• Biological drugs don't harm, but fix immunity: Experts (09-09-2024)

---

• Mumbai: Anti-Narcotics Cell Seizes 300 Codeine-Based Cough Syrup Bottles in Dharavi area (08-09-2024)

---

• Police seize 100 bottles of Eskuf cough syrup at Agartala railway station (08-09-2024)

---